Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Jun 22;17(6):e1009645. doi: 10.1371/journal.pgen.1009645

An enhancer screen identifies new suppressors of small-RNA-mediated epigenetic gene silencing

Yukiko Shimada 1, Sarah H Carl 1,2, Merle Skribbe 1,3, Valentin Flury 1,3, Tahsin Kuzdere 1,3, Georg Kempf 1, Marc Bühler 1,3,*
Editor: Michael Freitag4
PMCID: PMC8253403  PMID: 34157021

Abstract

Small non-protein coding RNAs are involved in pathways that control the genome at the level of chromatin. In Schizosaccharomyces pombe, small interfering RNAs (siRNAs) are required for the faithful propagation of heterochromatin that is found at peri-centromeric repeats. In contrast to repetitive DNA, protein-coding genes are refractory to siRNA-mediated heterochromatin formation, unless siRNAs are expressed in mutant cells. Here we report the identification of 20 novel mutant alleles that enable de novo formation of heterochromatin at a euchromatic protein-coding gene by using trans-acting siRNAs as triggers. For example, a single amino acid substitution in the pre-mRNA cleavage factor Yth1 enables siRNAs to trigger silent chromatin formation with unparalleled efficiency. Our results are consistent with a kinetic nascent transcript processing model for the inhibition of small-RNA-directed de novo formation of heterochromatin and lay a foundation for further mechanistic dissection of cellular activities that counteract epigenetic gene silencing.

Author summary

Besides silencing gene expression at the post-transcriptional level, small RNAs mediate the formation of silent chromatin that is heritable across generations. Over the last two decades, fission yeast has been serving as an excellent model organism to elucidate the mechanism of small-RNA-mediated heterochromatin formation at repetitive DNA. More recently, work performed with fission yeast revealed the existence of cellular activities that prevent small RNAs from triggering the formation of heterochromatin outside repetitive DNA. With the current work we are expanding the list of factors involved in these counteracting mechanisms. Our results support a model in which small-RNA-directed epigenetic gene silencing is controlled by pre-mRNA cleavage and underscore the importance of the mRNA 3`end processing machinery in warranting gene expression. Because the list of experimentally determined alleles that allow small-RNA-mediated heterochromatin formation keeps expanding, we speculate that fission yeast’s natural ecology may lead to the acquisition of silencing enabling genetic mutations as part of a biological bet-hedging strategy. We therefore advocate for the inclusion of non-laboratory strains in future research that aims at understanding the physiological relevance of small-RNA-mediated epigenetic gene silencing.

Introduction

Small RNAs are the common denominator of various RNA silencing pathways that regulate gene expression and protect the genome against mobile repetitive DNA sequences, retroelements, and transposons [13]. They function as specificity factors by guiding Argonaute protein-containing silencing complexes to their respective targets via base-pairing interactions [4, 5]. In the fission yeast Schizosaccharomyces pombe, endogenous small interfering RNAs (siRNAs) are indispensable for the maintenance of centromeric heterochromatin [6]. They originate from within centromeric heterochromatin and target the Argonaute-containing (Ago1) RNA-Induced Silencing Complex (RITS) in cis to nascent heterochromatic transcripts that are emanating from RNA polymerase II (RNA Pol II) transcribing the underlying repetitive DNA [7, 8]. Besides binding to nascent RNAs, RITS also binds to methylated histone H3 lysine 9 (H3K9me) through its chromodomain-containing subunit Chp1 [9, 10]. Constituting a positive feedback loop, the RITS complex recruits H3K9 methylation and RNA-dependent RNA polymerase activities to the locus it associates with [9, 1113]. Dicer-mediated (Dcr1) processing of the resulting double-stranded RNAs leads to amplification of the siRNA pool and thereby reinforcement of the positive feedback loop [14].

Whereas siRNAs originating from heterochromatic repeats function well in cis to sustain H3K9 methylation, they do not act in trans to mediate de novo formation of heterochromatin at complementary protein-coding genes outside centromeric repeats in wild-type cells [15]. Similarly, synthetic siRNAs produced from RNA-hairpins are not sufficient to stably silence homologous protein-coding genes through the assembly of heterochromatin [1619]. However, siRNAs have been shown to become potent mediators of RNAi-mediated epigenetic gene silencing in S. pombe cells that are mutant for mlo3+, dss1+, mst2+, or genes encoding subunits of the Paf1 complex (Paf1C) [15, 18, 20, 21]. Indicating potential evolutionary conservation, Paf1C also opposes PIWI/piRNA-directed silencing in Drosophila melanogaster [22].

Current understanding of the mechanisms that counteract small-RNA-mediated epigenetic gene silencing is in its infancy. Furthermore, rates at which silencing is initiated or maintained vary substantially between the different enabling mutations identified so far. For example, initiation of gene silencing was reported to occur in approximately 0.5–2% of mlo3Δ cells [15]. Silencing in Paf1C mutants is initiated in up to 20% of cells and is boosted to more than 80% upon additional deletion of the mst2+ gene [18, 20]. Although initiation of heterochromatin assembly in mlo3Δ and Paf1C mutant cells is not efficient, the silent state is stably maintained once established, even when cells undergo meiosis. That is, Mendelian segregation of the silent allele was observed irrespective of the primary siRNA trigger and enabling mlo3+ deletion in one study [15]. Inheritance of the repressed state induced by hairpin-derived siRNAs remains dependent on the enabling mutations in Paf1C but ensues independently of the hairpin trigger as well [15, 18, 23]. Here, inheritance patterns of the silencing phenotype violate Mendel’s laws, reminiscent of the paramutation phenomenon [18, 23, 24].

Whereas the role of the RNA export factor Mlo3 in counteracting small-RNA-mediated epigenetic gene silencing remains enigmatic, two non-mutually exclusive models have been put forward for Paf1C [25]. The first model suggests that dilution of K9 methylated H3 is lowered by the reduced histone H3 exchange rates in Paf1C mutants, stabilizing the H3K9 methylation state and hence the aforementioned positive feedback loop [26]. The second model suggests that mutations in Paf1C reduce the kinetics of nascent transcript release from chromatin, allowing sufficient time for RITS to recruit H3K9 methylation and RNA-dependent RNA polymerase activities that are necessary to initiate and propagate the positive feedback loop [18]. This model is supported by observations that alterations in the polyadenylation signal (PAS) of a target pre-mRNA enable siRNA-directed H3K9 methylation [27]. Yet, mutations in the pre-mRNA cleavage and polyadenylation machinery that would impair nascent transcript cleavage and hence potentially enable small-RNA-directed de novo formation of heterochromatin formation have not been identified. Thus, additional evidence supporting the second model is wanted.

In this study we have combined chemical mutagenesis with whole-genome sequencing in a sensitized reporter strain to obtain a more comprehensive list of putative suppressors of small-RNA-mediated epigenetic gene silencing. This revealed more than 20 novel silencing-enabling mutations in genes that are associated with RNA processing, regulation of transcription, or post-translational protein modification. Focusing on factors involved in pre-mRNA cleavage and polyadenylation, we show that single amino acid substitutions in Yth1, which is responsible for PAS recognition, lead to nearly 100% effective de novo formation of silent heterochromatin. Our work provides further support for a kinetic model for the inhibition of small-RNA directed de novo formation of heterochromatin and demonstrates that epigenetic gene silencing can be enabled by the acquisition of a plethora of mutant alleles in fission yeast.

Results

An enhancer screen identifies 20 novel mutant alleles that enable small-RNA-mediated epigenetic gene silencing

To identify novel factors that suppress the susceptibility of protein-coding genes for epigenetic silencing via siRNAs that are acting in trans, we employed an ade6+-based reporter system and whole-genome sequencing pipeline of a previous screen that had revealed Paf1C as a potent inhibitor of siRNA-directed heterochromatin formation [18]. ade6+ is a suitable reporter because Ade6-deficient cells form red colonies on limiting adenine indicator plates, whereas ade6+ expressing cells appear white. This allows simple assessment and quantification of the initiation, maintenance, and inheritance of siRNA-mediated silencing [28].

Because deletion of the mst2+ gene substantially increases the rate at which silencing is established de novo in Paf1C mutant cells [20], we created a sensitized reporter strain in which the mst2+ gene was deleted, and a RNA hairpin (ade6-hp) complementary to 250 nt of the trp1+::ade6+ reporter was expressed from the nmt1+ locus on chromosome I (Fig 1A). In the absence of additional enabling mutations, the siRNAs generated from the ade6-hp do not stably silence the complementary trp1+::ade6+ reporter gene in trans in a mst2Δ background [20](Fig 1A). To screen for mutants that would enable ade6 siRNAs to establish and maintain robust trp1+::ade6+ silencing, we mutagenized our sensitized reporter strain with ethylmethansulfonate (EMS). This was followed by several selection and triaging steps before the introduced mutations were finally mapped by whole-genome sequencing (Fig 1B).

Fig 1. Enhancer screen to identify mutant alleles that enable small-RNA-mediated epigenetic gene silencing.

Fig 1

(A) Schematic representation of the tester strains (mst2+ or mst2Δ) used in this study. Primary ade6 siRNAs are produced from the nmt1+ locus on chromosome I (green). They can only induce silencing of the ade6+ reporter gene on chromosome II, if the tester strain acquires an enabling mutation (white color of the colonies shown indicates expression of the ade6+ reporter gene despite the presence of ade6 siRNAs in these cells). (B) Workflow of the EMS mutagenesis screen. For the initial screening, a mst2Δ tester strain was used. Final hit validation was performed in mst2+ cells. (C) Representative images of validated point-mutations that are sufficient to enable RNAi-directed ade6+ silencing, which is indicated by the red color. Colonies showing a silencing phenotype on YE-NAT (100ug/ml nourseothricin) plates were selected and spread on YE plates to monitor stability of ade6+ repression. Cells are mst2+ but harbor mutations in individual genes as indicated.

Of roughly 280’000 EMS treated single cell derived colonies, about 700 colonies showed red or red/white variegating phenotypes. To select against loss-of-function mutations in the adenine biosynthesis pathway, these colonies were grown in the absence of adenine. Clones that were still able to grow were subsequently shifted to 37°C. At this temperature, the repressed state of a heterochromatinized ade6+ reporter gene is reversed, i.e. white instead of red colonies are formed. At this step, we ended up with 103 colonies in which the trp1+::ade6+ reporter gene was silenced epigenetically (showing white and red phenotypes at 37°C and 30°C, respectively). After these were backcrossed four times, mutations that segregated with an ade6+ repression phenotype were mapped by whole-genome next-generation sequencing (S1 Table). Validating our screen, four clones had acquired mutations in subunits of the Paf1C complex. In another clone we found a nonsense mutation in the res2+ gene, which we had previously shown to display a weak silencing phenotype when deleted (Table 1) [18]. Thus, our screen reliably identifies mutants that enable small-RNA-mediated epigenetic gene silencing, even if initiation rates are poor.

Table 1. Anticipated genes with mutations mapped by whole-genome sequencing.

systematic ID protein mutation
SPAC664.03 Paf1, Paf1 complex G102S
SPAC664.03 Paf1, Paf1 complex Q170Stop
SPBC651.09c Prf1, Paf1 complex E435K
SPBC651.09c Prf1, Paf1 complex A439T
SPAC22F3.09c Res2 Q41Stop

To validate the mapped sequence alterations (S1 Table) as the causative mutations, and to test if they could also function independently of impaired Mst2 activity, we reconstituted the candidate point mutations in our original tester strain (mst2+) [18]. This revealed 20 novel silencing-enabling point mutations, which reliably recapitulated the ade6+ silencing phenotype (Fig 1C). Consistent with small-RNA-mediated epigenetic silencing responses, the ade6+ repression phenotypes were reversible and depended on a functional dcr1+ allele in all 20 strains (S1 and S2 Figs). Eight of these novel enabling mutations were found in genes associated with RNA processing, four in genes encoding regulators of transcription, and three in genes that have been implicated in post-translational modification of histones. Another five mutations were found either in genes of unknown function or in genes related to lipids (Table 2). In conclusion, our enhancer screen has identified 20 novel high confidence alleles that enable siRNAs to induce gene silencing in trans.

Table 2. Newly identified and validated enabling mutations.

systematic ID protein complex mutation biological process dcr1Δ
SPAC227.08c Yth1 CPF R59C polyadenylation signal recognition
SPAC29B12.06c Rcd1 CCR4-NOT L212I poly(A) tail shortening
SPCC330.10 Pcm1 Capping complex G218S mRNA capping
SPCC10H11.01 Prp11 U2 prespliceosome R677K mRNA splicing
SPAC17A5.02c Dbr1 spliceosome Q277Stop mRNA splicing, RNA lariat debranching
SPAC9.03c Brr2 U5 snRNP G2014S mRNA splicing
SPAC2C4.07c Dis32 . . . D65N 3’-5’ RNA degradation
SPAC19A8.08 Upf2 . . . S726I nonsense-mediated mRNA decay
SPAC589.02c Med13 Mediator D1064N regulation of transcription
SPAC22H10.11c Crf1 . . . D598N regulation of transcription, TOR signaling
SPBC1773.16c . . . . . . V392F regulation of transcription, DNA binding
SPCC24B10.08c Ada2 SAGA P265L regulation of transcription, stress response
SPAC343.11c Msc1 Swr1 complex W357Stop H3K36 demethylation, histone exchange
SPAC637.12c Mst1 NuA4 T397I histone acetylation
SPCC4G3.07c Phf1 Lsd1/2 complex A179T histone H3K9 demethylation
SPBC19C2.06c Mug124 . . . S98N S. pombe specific protein, uncharacterized
SPBC1A4.04 . . . . . . T141I S. pombe specific protein, uncharacterized
SPBPB21E7.10 . . . . . . Q2Stop S. pombe specific protein, uncharacterized
SPAC9G1.08c . . . . . . S53N protein depalmitoylation
SPBC1289.04c Pob1 . . . A699T lipid binding, regulation of exocytosis

Arginine to cysteine substitution in the Yth1 cleavage/polyadenylation factor enables efficient initiation of heterochromatin-mediated gene silencing

Among all mutants tested, cells with an arginine to cysteine mutation at position 59 in the yth1+ gene (yth1-R59C) displayed the strongest silencing phenotype (Figs 1C, 2A and 2B). The Yth1 protein is a subunit of the cleavage and polyadenylation factor complex (CPF) and is responsible for the recognition of the AAUAAA polyadenylation signal in pre-mRNAs [29]. This is interesting because a previous study highlighted the importance of the PAS in preventing the formation of heterochromatin [27].

Fig 2. Arginine to cysteine substitution in Yth1 enables small-RNA-directed heterochromatin assembly.

Fig 2

(A and B) Silencing assays showing the ade6+ silencing phenotype in yth1-R59C mutant cells. Silencing in individual colonies is typically variegating (A), which is lost in cells lacking either Dicer (dcr1Δ) or the ade6 RNA hairpin (ade6-hp) (B). (C and D) Comparison of initiation (C) and maintenance (D) of ade6+ silencing in paf1-Q264Stop and yth1-R59C cells (trp1+::ade6+, nmt1+::ade6-hp+). Multiple individual originator colonies (white or red in C or D, respectively) were spread to single cell density on YE plates to assess initiation/maintenance of the silencing phenotype: n = 6 for paf1-Q264Stop white originator (C, total counted number of colonies = 2547), n = 6 for paf1-Q264Stop red originator (D, total counted number of colonies = 3016), n = 12 for yth1-R59C white originator (C, total counted number of colonies = 4063), n = 9 for yth1-R59C red originator (D, total counted number of colonies = 9468). (E) ChIP analysis of H3K9me2 in the strains indicated (trp1+::ade6+, nmt1+::ade6-hp+). Fold enrichments were normalized to adh1+ and are shown relative to background levels measured in clr4Δ cells. Error bars indicate standard deviation, n = 3 independent biological replicates, p-values were calculated with a two-tailed Student’s t-test. The ade6+ primer pairs do not discriminate between endogenous ade6-704 and trp1+::ade6+ genes. (F) Small RNA sequencing was performed with yth1+ and yth1-R59C cells to assess secondary ade6+ siRNA production. Read counts were normalized to library size. The part of ade6+ that is complementary to the primary siRNAs encoded by the ade6-hp is denoted.

Stability of a heterochromatin-mediated silencing phenotype depends on the rate at which heterochromatin is established, or on the robustness of the mechanisms that preserve the silent chromatin state through mitosis, or both. For example, in Paf1C mutant cells, silencing is established rather inefficiently, but it is very stably propagated through subsequent cell divisions [18, 20](Fig 2C and 2D). In yth1-R59C cells, we observed an initiation rate of silencing that was close to 100% (Fig 2C). Silencing was maintained stably but appeared more variegating than the silencing phenotype observed in Paf1C mutants (Fig 2A and 2D). Furthermore, we also observed silencing in yth1-R59C cells that express synthetic ura4-hp siRNAs instead of ade6-hp siRNAs, and a trp1+::ura4+ instead of a trp1+::ade6+ reporter (S3A Fig). Thus, we conclude that the yth1-R59C allele enables trans-acting siRNAs to effectively initiate the formation of heterochromatin at their target locus.

The silencing phenotypes described above, together with its temperature-sensitivity, strongly imply RNAi-mediated heterochromatin formation at the target locus. To formally demonstrate this, we assessed initiation of silencing of the trp1+::ade6+ reporter gene in yth1-R59C cells lacking either a functional dcr1+ gene or the primary siRNA producing nmt1+::ade6-hp+ locus. We observed silencing in neither of these strains (Fig 2B), demonstrating the necessity of siRNA biogenesis. To confirm the formation of a heterochromatic structure at the trp1+::ade6+ locus, we performed chromatin immunoprecipitation (ChIP) experiments using an antibody specifically recognizing di-methylated lysine 9 on the N-terminal tail of histone H3 (H3K9me2). As predicted, the H3K9me2 mark was significantly enriched in yth1-R59C cells. yth1+ cells were not different from cells lacking Clr4, which is the sole H3K9 methyltransferase in S. pombe (Fig 2E). Finally, assembly of heterochromatin at the trp1+::ade6+ reporter gene was accompanied by the production of secondary ade6+ siRNAs that are not encoded in the ade6-hp (Fig 2F).

These results demonstrate that replacing arginine at position 59 of Yth1 with a cysteine does not critically affect expression of the trp1+::ade6+ reporter gene (Fig 2B). However, it enables highly efficient initiation of heterochromatin-mediated gene silencing upon expression of primary siRNAs that are complementary to the ade6+ pre-mRNA (S3B and S3C Fig).

PAS recognition controls small-RNA-mediated epigenetic gene silencing

CPF is a large multisubunit protein complex possessing ATP-polynucleotide adenylyltransferase, phosphatase, and nuclease activities that are required for the cleavage and polyadenylation of pre-mRNA transcripts [29]. Yth1 is part of the poly(A)polymerase module of CPF and is essential for cellular viability [30]. Because 3’ end processing of pre-mRNAs has previously been implicated in the control of RNA silencing pathways in yeast, flies, and plants [18, 27, 3135], the identification of yth1-R59C as a silencing-enabling allele is appealing. Because our EMS screen revealed only one enabling mutation residing in Yth1, we decided to perform a directed evolution experiment to select additional putative yth1 alleles that would promote small-RNA-mediated epigenetic gene silencing.

We cloned the yth1+ gene in a hph+-marked plasmid (p-yth1+/hph+), which we subsequently propagated in the E. coli XL1-Red mutator strain to produce a randomly mutagenized plasmid library (p-yth1*/hph+)[36]. This library was then transformed into our S. pombe tester strain (mst2+) [18], in which we deleted the endogenous yth1+ gene, to screen for silencing-enabling Yth1 mutants. Because yth1Δ cells are not viable, this modified tester strain (mst2+) was rescued with a ura4+-marked yth1+ expression plasmid (p-yth1+/ura4+). Upon transformation with the mutant p-yth1*/hph+ library, loss of the p-yth1+/ura4+ rescue plasmid was forced by growth on medium containing 5-fluoroorotic acid, which is toxic to ura4+ expressing cells (Fig 3A). Thus, complete loss of function Yth1 mutants were counter-selected during this step of the experiment. To find small-RNA-mediated epigenetic gene silencing-enabling Yth1 mutants, we grew the p-yth1*/hph+ expressing tester strain (mst2+) on low adenine plates and isolated single colonies that displayed an ade6+ silencing phenotype (Fig 3B). Sanger sequencing of the recovered p-yth1*/hph+ plasmids revealed seven residues that were mutated: 2x R59C, 1xK55N, 2x E73K, 1x Y74H, 4x C91Y, 1x C91R, and 1x Y99H (Fig 3C). Because the R59C mutation was found again twice and C91 was mutated five times, this screen might have reached saturation.

Fig 3. Weakening CPF/AAUAAA RNA interactions enables small-RNA-mediated epigenetic gene silencing.

Fig 3

(A) Workflow of the yth1+ random mutagenesis screen. The mutant yth1* plasmid library was transformed into the tester strain (mst2+) lacking the endogenous yth1+ gene. The ade6-hp construct (primary siRNA source) is indicated in green. (B) yth1 mutants that display an ade6+ silencing phenotype on YE plates. The numbers in brackets denote how many times the respective mutation was recovered in the screen. (C) Domain organization of the Yth1 protein. Grey boxes indicate the CCCH zinc finger domains. Asterisks denote the recovered mutations. (D) Modelling of point-mutations using PyMOL. The structure of human CPSF-30 in complex with CPSF-160, WDR33 and PAS RNA (PDB ID 6DNH) was selected as homology model for the S. pombe complex. Insets show wild-type residues compared to the modelled point mutations. The numbering corresponds to S. pombe Yth1. Zinc ions are shown as spheres. Putative π-stacking interactions are indicated by dashes with varying broadness based on estimated interaction strength. (E) Initiation frequency of ade6+silencing in cells harboring mutations at the 4th position in the PAS of the ade6+ reporter gene. At least eight individual white originator colonies per indicated genotype were spread to single cell density on YE plates. Total number of colonies counted: 1734 (AAUAAA without siRNAs), 1605 (AAUUAA without siRNAs), 1324 (AAUGAA without siRNAs), 1312 (AAUCAA without siRNAs), 1957 (AAUAAA with siRNAs), 1790 (AAUUAA with siRNAs), 2314 (AAUGAA with siRNAs), 2144 (AAUCAA without siRNAs). Primary siRNAs are encoded by the ade6-hp construct. (F) Silencing assay demonstrating siRNA-directed ade6+ silencing in pfs2-F115H cells specifically. The ade6-hp construct (primary siRNA source) is indicated in green. (G) Initiation and maintenance of ade6+ silencing in pfs2-F115H cells. Four individual originator colonies (white for initiation, red for maintenance) were spread to single cell density on YE plates. 361 and 665 colonies were counted to determine initiation and maintenance frequencies, respectively.

Because protein structures of S. pombe CPF have not yet been determined, we selected the structure of human CPSF-30 (homolog of S. pombe Yth1) in complex with CPSF-160 (homolog of S. pombe Cft1), WDR33 (homolog of S. pombe Pfs2), and PAS RNA as a homology model to infer the functional consequences of the enabling mutations that we have identified (PDB ID 6DNH) [37]. This revealed that mutations in E73 and Y74 are likely to disturb the Yth1-Cft1 interaction and the C91R mutation the Yth1-Pfs2 interaction, whereas the other mutations are predicted to weaken the interaction with the PAS in the pre-mRNA (Fig 3D). Interestingly, K55, R59, C91, and Y99 contribute to the binding of Yth1 to the adenosine at position 4 (A4) of the PAS, suggesting that an adenosine at position 4 is critical for the prevention of silencing. Indeed, mutating A4 in the trp1+::ade6+ reporter to either U, C, or G enabled siRNAs to initiate silencing (Figs 3E and S3B). Further supporting the importance of PAS recognition, we observed siRNA-dependent trp1+::ade6+ reporter silencing upon mutation of F115 in Pfs2 (Figs 3F and S3D), which stacks with A6 of the PAS (Fig 3D).

Interestingly, initiation frequency of the silencing response was lower in pfs2-F115H cells than observed with A4 PAS mutants (Fig 3E and 3G). Yet, once established the silent state was remarkably stably maintained (Fig 3G). We note that residue C91 is part of the second CCCH zinc finger motif in Yth1. Correct folding of this zinc finger is important for binding A4/A5 in the PAS as well as for the interaction of Yth1 with Pfs2 (Fig 3D). Thus, Yth1-C91 mutations are likely to stimulate both initiation and maintenance of silencing, providing a potential explanation why we have mapped C91 five times in this screen.

Deletion of non-essential subunits of the phosphatase module of the cleavage and polyadenylation factor complex enables small-RNA-mediated epigenetic gene silencing

The foregoing results implicate the fission yeast CPF in the control of small-RNA-mediated epigenetic gene silencing. Because we have mapped enabling mutations in the poly(A) polymerase-module of CPF only, we asked whether mutations in the other modules would similarly enable silencing. Unfortunately, the genes encoding subunits of the nuclease module are essential for viability [30], preventing us from testing those. However, we were able to delete the dis2+, ppn1+, swd22+, and ssu72+ genes, which encode subunits of the phosphatase module (Fig 4A). Like the poly(A) polymerase module mutants, the four phosphatase module knock-out strains enabled small-RNA-mediated gene silencing (Figs 4B and 4C and S4A–S4C). Interestingly, Swd22 and Ssu72 have recently been shown to be required for RNAi-independent assembly of facultative heterochromatin [32]. Thus, the phosphatase module of CPF may have opposing roles depending on the pathway that leads to H3K9 methylation.

Fig 4. Mutations in the phosphatase module of CPF enable small-RNA-mediated epigenetic gene silencing.

Fig 4

(A) Phosphatase, nuclease, and poly(A) polymerase modules of CPF, adapted from a model of budding yeast CPF [29]. Subunits found in this study to enable siRNA-mediated gene silencing when mutated are indicated by filled circles and their protein names. (B) Silencing assay showing the degree of ade6+ silencing in cells with an impaired phosphatase module of CPF. Ssu72 and Dis2 are active phosphatases. See also S4 Fig. (C) Small RNA sequencing was performed with the strains indicated to assess secondary ade6+ siRNA production. Read counts were normalized to library size. The part of ade6+ that is complementary to the primary siRNAs encoded by the ade6-hp is denoted.

A remarkable feature of CPF mutants that we have investigated in this study is that they by and large phenocopy wild-type cells, i.e. neither growth nor global gene expression is largely affected (S5 Fig). For example, we did not observe any major differences in steady-state ade6+ mRNA levels in CPF or PAS mutant cells in the absence of ade6 siRNAs (Figs 5A and 5B and S5A). Also, polyadenylation of ade6+ mRNA in wild-type and mutant cells was indistinguishable in our assay (Fig 5B). However, we observed compromised cleavage of the ade6+ pre-mRNA, which was prominent in many of the mutants investigated (Fig 5A upper panel and 5C). This strongly implies reduced kinetics of the 3’ end processing reaction.

Fig 5. Silencing enabling mutations in the PAS of a siRNA target pre-mRNA or the poly(A) polymerase module, but not the phosphatase module of CPF, affect pre-mRNA cleavage.

Fig 5

(A) Qualitative RT-PCR with primer pairs amplifying amplicons before (lower panel) and across (upper panel) the PAS and major cleavage site of the ade6+ pre-mRNA. See S4 Table for primer sequences. (B) RT-PCR amplifying polyadenylated ade6+ mRNA using an anchored oligodT primer (green arrow). (C) Quantitative RT-PCR with primer pairs binding to the ORF (amplicons A and B) or up- and downstream of the cleavage site (amplicon C) of the ade6+ pre-mRNA (upper panel), or primer pairs binding to the ORF (amplicons D and E) or up- and downstream of the cleavage site (amplicon F) of the lys4+ pre-mRNA (lower panel). Positions of the primer pairs are shown in the schematics on the left (not drawn to scale). Note that the PAS mutations indicated in the lower panel refer to the ade6+ PAS. The lys4+ PAS was not mutated in these samples. Error bars indicate standard deviation, n = 3 or 4 independent biological replicates for lys4+ or ade6+, respectively. (A—C) cDNA was prepared from RNA that was isolated from cells with the indicated genotype. These cells did not express ade6+ siRNAs.

In conclusion, our results are consistent with previous works that have implicated pre-mRNA processing factors in small-RNA-mediated silencing responses [15, 18, 31]. Our detailed analyses of S. pombe CPF mutants reinforce the importance of an efficient 3’ end processing reaction to avoid an unwanted gene silencing response.

Discussion

In this study we have identified novel mutant alleles that make S. pombe susceptible for RNAi-mediated de novo assembly of silent chromatin. Though we have focussed on a functional dissection of mutations in the pre-mRNA cleavage and polyadenylation machinery in this study (Fig 4A), it will be equally exciting to dissect the role of the other RNA processing factors that our screen has revealed. Likewise, further investigating the many alleles linked to chromatin biology or transcription regulation promises to further improve our understanding of the intricate mechanisms that keep RNA-mediated epigenetic processes in check (Table 2).

Our work on CPF presented here is consistent with our previously proposed kinetic model for the inhibition of de novo formation of heterochromatin that is mediated by trans-acting primary siRNAs. In this model, the rate at which the nascent transcript is released from the DNA template is predicted to constitute a rate limiting step for the initiation of heterochromatin assembly and eventually gene silencing [18]. We find it striking that ade6+ pre-mRNA cleavage in yth1-R59C cells is similarly affected as in cells harbouring ade6+ genes with A4 mutated PASs (Fig 4B and 4C). As predicted by the kinetic model, mutations that we have mapped in CPF are thus likely to result in decelerated cleavage and release of the nascent transcript from the site of transcription, opening up a window of opportunity for the siRNA-guided RITS complex to base-pair with pre-mRNA and recruit the histone methylation machinery. Such a model nicely explains why the initiation rates that we have observed in yth1-R59C cells are so remarkably high (Fig 2C).

Although we could not investigate factors of the CPF nuclease module, we deleted four genes that are encoding subunits of the phosphatase module. While to seemingly various degrees, all four mutants enabled silencing. This is intriguing because Ssu72 and Dis2 are active phosphatases, letting us to speculate that inhibition of RNAi-mediated heterochromatin formation could be regulated by kinase signalling pathways. This is of particular interest in light of a recent report that described the isolation of heterochromatin-dependent epimutants that are resistant to caffeine, which is abolished in RNAi mutants [38]. A similar phenomenon had been described earlier in Mucor circinelloides, which can cause deadly fungal infections in humans. Similar to S. pombe responding to low doses of caffeine, M. circinelloides can become resistant against antifungal drugs through RNAi-mediated epigenetic gene silencing [39, 40]. It is tempting to speculate that sensing of toxic substances in the environment could be signalled to the RNAi-inhibiting modules that we have identified in our works. Potential modulation of such signalling by the CPF phosphatases is an attractive hypothesis that will be worthwhile further investigation.

Although regulation of RNAi-mediated epigenetic gene silencing through direct environmental sensing is appealing, we do not exclude the possibility that RNAi-mediated de novo formation of heterochromatin on protein-coding genes strictly depends on the acquisition of an enabling mutation. In this model, an epigenetic gene silencing response would always be preceded by a genetic change. This is supported by the many different enabling genetic mutations that we and others have identified so far [15, 18, 20], and by our unsuccessful efforts to trigger small-RNA-mediated gene silencing under various environmental conditions in wild-type cells. Thus, we urge the community to consider the possibility that acquisition of a genetic mutation had preceded the establishment of the observed siRNA-triggered epigenetic silencing phenotype, especially when “on” and “off” expression states segregate with a 2:2 Mendelian ratio in seemingly wild-type cells [15]. As we have already discussed elsewhere, prior acquisition of RNAi-enabling genetic mutations could also explain why virulent isolates of M. circinelloides have an enhanced ability to develop drug resistance through epimutations [25].

The latter model would be fully consistent with the concept of biological bet-hedging, as enabling stochastic RNAi-mediated epigenetic silencing might help the microbe to adapt to an ever-changing environment [25]. Therefore, it could be advantageous for a yeast to hedge its bets by acquiring an enabling mutation in case its environment keeps changing. Because this comes along with decreased fitness in stable conditions, such mutations would be expected to disappear in a laboratory strain. This may explain why S. pombe cells that we are growing in our labs are refractory to RNAi-mediated gene silencing.

Materials and methods

Yeast strains

S. pombe strains were generated following a PCR-based protocol [41] or by standard mating and sporulation. For a list of strains generated in this study see S2 Table.

As a general procedure to validate the newly identified enabling alleles, the mapped mutations were introduced in the mst2+ tester strain by transformation of the mutated ORF, which was marked with URA3 from Candida albicans. After successful integration, URA3 was removed by FOA counter selection. To mutate dis32+, the ORF was deleted with URA3, which was subsequently replaced by transformation of the mutated dis32+ ORF and FOA counter selection. The SPBPB21E7.10-Q2Stop early ORF truncation was generated by the insertion of an hphMX cassette.

Plasmids

Plasmids were cloned by standard molecular biology techniques. For a list of plasmids generated in this study see S3 Table. The plasmid expressing yth1+ and ura4+ (pMB1869) was constructed by cloning yth1+, including 978bp upstream and 530bp downstream sequence, into KpnI/PstI digested pFY20, which was a kind gift from Mari K. Davidson. To generate the hph+ marked plasmids, the ura4+ marker of pFY20 was first replaced with hph+ (pMB1867).

EMS mutagenesis, hit selection, and backcrossing

SPB2970 cells (h- leu1-32 ura4-D18 ade6-M210 trp1+::ade6+ nmt1+::ade6-hp+::natMX mst2Δ::kanMX) were mutagenized as described previously [18]. Clones that grew on medium lacking adenine and lost the red color phenotype at 37°C were backcrossed four times with the parental strains SPB2970 or SPB2971, depending on the mating type (h- or h+, respectively).

Whole-genome sequencing

Genomic DNA was isolated from overnight cultures using the MasterPure yeast DNA isolation kit (Epicentre). Genomic DNA libraries for next-generation-sequencing were prepared from 50ng of sonicated DNA, using the NEBnext Ultra kit (NEB) following the manufacturer’s protocol. Libraries were sequenced 50bp single-end on the Illumina HiSeq2500 platform. Basecalling and quality scoring was performed using RTA v1.18.64, and demultiplexing using bcl2fastq2 v2.17 (Illumina). For SNP calling we adapted a previously described pipeline [18]: For each strain, between 6.4 and 17.6 million (mean of 11.5 million) 50-nucleotide reads were generated and aligned to the Schizosaccharomyces pombe 972h- genome assembly (obtained on 17 September 2008 from http://www.broad.mit.edu/annotation/genome/schizosaccharomyces_group/MultiDownloads.html) using ‘bwa’ (version 0.7.15) with default parameters, but only retaining single-hit alignments (‘bwa samse -n 1’ and selecting alignments with ‘X0:i:1’), resulting in a genome coverage between 26 and 71-fold (mean of 47-fold). The alignments were converted to BAM format, sorted and indexed using ‘samtools’ (version 1.3.1). Potential PCR duplicates were removed using ‘MarkDuplicates’ from ‘Picard’ (http://picard.sourceforge.net/, version 2.7.1). Sequence variants were identified using GATK (version 3.6) indel realignment and base quality score recalibration. A set of high confidence variants was identified in an initial step as known variants, followed by single nucleotide polymorphism (SNP) and INDEL discovery and genotyping for each individual strain using standard hard filtering parameters, resulting in a total of 14–103 sequence variants (mean of 68) in each strain compared to the reference genome. Finally, variants were filtered to retain only high quality single nucleotide variants (QUAL > = 50) of EMS type (G|C to A|T) with an allelic balance > = 0.9 (homozygous) that were not also identified in the parental strain (sms0), reducing the number of variants per strain to a number between 1 and 8 (mean of 3.6).

Random mutagenesis of yth1+

To generate a mutant yth1 plasmid library (p-yth1*/hph+), p-yth1+/hph+ (pMB1870) was transformed into E. coli XL1-Red competent cells (Agilent). More than 200 transformed colonies were picked randomly, pooled and grown over night at 37°C before plasmids were isolated with the PureYield Plasmid Midiprep System (Promega).

Selection of silencing-enabling yth1 mutants

To rescue growth of yth1Δ S. pombe cells, they were first transformed with an yth1+ expressing plasmid (pMB1869) before the endogenous yth1+ gene was deleted with a kanMX cassette, resulting in the strain SPB3646. SPB3646 was transformed with the mutant p-yth1*/hph+ library and grown on YES plates for 2 days at 30°C. Cells were then replica plated on YE plates supplemented with 0.226g/l leucine, 0.226g/l lysine, 0.226g/l histidine, 0.226g/l uracil, 2g/l FOA and 100mg/l Hygromycin B (YE4S+FOA+Hygromycin B). Plasmids were recovered from yeast colonies with a silencing phenotype and subsequently sequenced by Sanger-sequencing. To confirm the silencing phenotype, the isolated plasmids were transformed in SPB3646, followed by growth on YE4S+FOA+Hygromycin B plates to force loss of the yth1+ rescue plasmid and to score for colony color.

Silencing assays

To assess ade6+ expression, serial five-fold dilutions of the respective strains were plated on yeast extract (YE) plates and incubated at 30°C for 3–4 days. Plates were stored at 4°C overnight before pictures were taken.

To quantify initiation and maintenance rates of silencing, either single-cell-derived white (for initiation) or red (for maintenance) colonies were selected from a YE-NAT plate. A single colony was resuspended in H2O and 50–500 cells were seeded on YE plates, which were incubated at 30°C for 4 days. Colonies were categorized and counted, after an additional overnight incubation at 4°C, using a deep learning pipeline for high-throughput colony segmentation and classification [28].

Chromatin immunoprecipitation (ChIP)

ChIP experiments were performed as described previously [18] with a histone H3K9me2-specific mouse monoclonal antibody from Wako (clone no. MABI0307).

RNA isolation and cDNA synthesis

Total RNA was isolated using the MasterPure Yeast RNA Purification Kit (Epicentre). cDNA was synthesized using the PrimeScript RT Master Mix (Takara).

Small and total RNA sequencing and analysis

Small RNA libraries were prepared with the QIAseq miRNA Library Kit (QIAGEN, Cat. No: 331505) according to the manufacturer’s instructions and sequenced with an Illumina NextSeq500 (75bp single-end). 3’ adapter sequences were trimmed using cutadapt [42](version 1.18) (cutadapt -a ‘adapter’—discard-untrimmed -m 18) and untrimmed or <18nt long reads were discarded. The remaining reads were aligned to the S. pombe genome (ASM294 version 2.24) using bowtie [43] (version 1.2.2) (bowtie -f -M 10000 -v 0 -S—best—strata). Displayed are UCSC genome browser [44] tracks of uniquely mapped reads that are normalized to one million reads (RPMs).

Total RNA libraries were prepared with TruSeq Stranded Total RNA kit (Illumina, Cat. No: 20020599) according to the manufacturer’s instructions and sequenced with an Illumina HiSeq2500 (50bp single-end). RNA-seq reads were aligned to the S. pombe genome (ASM294 version 2.24) using STAR [45] (version 2.7.3a) (STAR—runMode alignReads—outFilterType BySJout—outFilterMultimapNmax 100—outFilterMismatchNoverLmax 0.05—outSAMmultNmax 1—outMultimapperOrder Random—outSAMtype BAM SortedByCoordinate—outSAMattributes NH HI NM MD AS nM—outSAMunmapped Within). The reads per gene were counted with featureCounts [46] of uniquely mapping reads only (useMetaFeatures = TRUE, allowMultiOverlap = FALSE, minOverlap = 5, countMultiMappingReads = FALSE, fraction = FALSE, minMQS = 255, strandSpecific = 2, nthreads = 20, verbose = FALSE, isPairedEnd = FALSE). An external feature annotation file for S. pombe was used based on a GFF3 file from PomBase [30] that was converted to a GTF file with rtracklayer [47]. Fragments per kilobase million (FPKMs) were calculated and averaged over three replicates. Each scatterplot depicts log2-transformed FPKM values of the wild-type against one of the mutants.

Small RNA and total RNA sequencing data have been deposited at the NCBI Gene Expression Omnibus (GEO) database and are accessible through GEO series number GSE173837.

Quantitative real-time PCR

Real-time PCR on cDNA samples and chromatin immunoprecipitation (ChIP) DNA was performed as described using a Bio-Rad CFX96 real-time system using SsoAdvanced SYBR Green supermix (Bio-Rad) [48]. For primer sequences see S4 Table.

Qualitative RT–PCR

PCR on cDNA was performed using the fast-cycling PCR kit (Qiagen). PCR products were analyzed by agarose gel electrophoresis. Primer sequences are listed in S4 Table.

3’ RACE

3’ RACE to assess PolyA tail length was performed as described elsewhere [49]. Briefly, first strand cDNA was synthesized from total RNA with an anchored oligo-d(T)17VN primer using ProtScript reverse transcriptase (NEB). A first round of amplification was performed with primers mb7234 and mb13037. A second round of amplification was performed with primers mb135 and mb13038.

Structure modelling

The structure of human CPSF-30 in complex with CPSF-160, WDR33 and PAS RNA (PDB ID 6DNH) was selected as homology model for the S. pombe complex based on an HHpred search [50]. Positions of S. pombe Yth1 point mutations, which are located in zinc finger domains 1 and 2, were mapped to HsCPSF-30 by aligning both sequences using Clustal Omega [51]. Except for S. pombe Yth1 phenylalanine 99 being tyrosine in human CPSF-30, respective residues were identical. S. pombe Cft1 and Psf2 domains (aa 1117–1349 and aa 6–404) interacting with Yth1 zinc fingers 1 and 2 (aa 48–104) share 32% (55%), 45% (64%), and 69% (88%) identities (positives) with the human homologs, respectively, based on local sequence alignments using BLAST (aligned sequence ranges: aa 1117–1349 (SpCft1), aa 6–404 (SpPsf2), aa 51–104 (SpYth1) [52]).

This suggested adequate structural conservation that allowed the analysis of mutations in S. pombe in the context of the human complex. A model for these point mutations was generated by mutating mapped residues in HsCPSF-30 (6DNH) using PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC).

Supporting information

S1 Fig. ade6+ silencing in the newly identified point-mutants depends on a functional RNAi pathway.

Serial dilution assays showing the ade6+ silencing phenotypes (red color when grown on YE plates) in the respective mutant cells. Silencing is not observed in the absence of Dicer (dcr1Δ). Cells are mst2+ but harbor mutations in individual genes as indicated.

(TIF)

S2 Fig. Most of the newly identified point-mutants with a low silencing initiation rate have a higher maintenance of silencing rate.

Comparison of initiation (A) and maintenance (B) of ade6+ silencing in the mutant cells as indicated (trp1+::ade6+, nmt1+::ade6-hp+). Multiple individual originator colonies (white or red in A or B, respectively) were spread to single cell density on YE plates to assess initiation/maintenance of the silencing phenotype. Number of originator colonies and total counted number of colonies (in brackets) are indicated on top of the graphs.

(TIF)

S3 Fig. Expression of siRNAs in cells with weakened CPF/AAUAAA RNA interactions triggers RNAi-mediated heterochromatin silencing of protein coding genes in trans.

(A) RNAi-directed silencing in yth1-R59C cells is not unique to the trp1+::ade6+ silencing reporter. The yth1-R59C mutation was introduced into cells that express synthetic ura4-hp siRNAs instead of ade6-hp siRNAs, and a trp1+::ura4+ instead of a trp1+::ade6+ reporter. ura4DS/E denotes a partial deletion of the endogenous ura4+ gene. Silencing of the ura4+ reporter was assessed by growth in the presence or absence of 5-FOA (which is toxic to ura4+ expressing cells). Note that 5-FOA resistant colonies did only form in the presence of ura4-hp siRNAs and simultaneous mutation of yth1+. (B) Silencing assays showing the degree of ade6+ silencing in cells harboring mutations in yth1+ (yth1-R59C) or at the 4th position in the PAS of the ade6+ reporter gene. See Fig 3E for a quantification of the initiation of silencing rates in the PAS mutants. (C) Silencing assay demonstrating that trp1+::ade6+ silencing in yth1-R59C cells depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ). (D) Silencing assay demonstrating that trp1+::ade6+ silencing in pfs2-F115H cells depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ).

(TIF)

S4 Fig. Impairment of the CPF phosphatase module enables RNAi-mediated heterochromatin silencing.

(A) Silencing assays demonstrating that trp1+::ade6+ silencing in CPF phosphatase module mutant cells (ssu72Δ, swd22Δ, dis2Δ, ppn1Δ) depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ). (B and C) Comparison of initiation (B) and maintenance (C) of ade6+ silencing in CPF phosphatase module mutant cells (trp1+::ade6+, nmt1+::ade6-hp+). Multiple individual originator colonies (white or red in B or C, respectively) were spread to single cell density on YE plates to assess initiation/maintenance of the silencing phenotype. Number of originator colonies and total counted number of colonies (in brackets) are indicated on top of the graphs.

(TIF)

S5 Fig. Steady-state mRNA levels remain largely unaffected in cells harboring RNAi-enabling CPF mutations.

(A) Quantitative RT-PCR with primer pairs amplifying ade6+ or act1+ mRNAs in the respective mutant strains, which do not express any ade6+ siRNA. mRNA levels were normalized to U6snRNA and are shown relative to the levels measured in wild-type cells. Error bars indicate standard deviation, n = 3 independent biological replicates. (B) Pairwise comparisons of gene expression (RNA-seq) between wild-type and CPF or trp1+::ade6+ PAS mutant strains. Cells did not express primary ade6-hairpin siRNAs. Fragments per kilobase million (FPKMs) were calculated and averaged over three replicates. Each scatterplot depicts log2-transformed FPKM values of the wild-type against one of the mutants.

(TIF)

S1 Table. EMS type mutations identified by Illumina whole genome next-generation sequencing

(XLSX)

S2 Table. List of S. pombe strains used in this study.

(XLSX)

S3 Table. List of plasmids used in this study.

(XLSX)

S4 Table. List of primers used in this study.

(XLSX)

S1 Data. Values used to generate box plot shown in Fig 2C.

(XLSX)

S2 Data. Values used to generate box plot shown in Fig 2D.

(XLSX)

S3 Data. Values used to generate graph shown in Fig 2E.

(XLSX)

S4 Data. Values used to generate box plot shown in Fig 3E.

(XLSX)

S5 Data. Values used to generate box plot shown in Fig 3G.

(XLSX)

S6 Data. Values used to generate graphs shown in Fig 5C.

(XLSX)

S7 Data. Values used to generate box plots shown in S2 Fig.

(XLSX)

S8 Data. Values used to generate box plots shown in S4B and S4C Fig.

(XLSX)

S9 Data. Values used to generate graph shown in S5A Fig.

(XLSX)

Acknowledgments

We thank N. Laschet for technical assistance, H. Gut for help with the design of CPF mutations, M. K. Davidson for providing the plasmid pFY20, and E. P. F. Moreno, K. Hirschfeld, and S. Smallwood for library construction and next-generation sequencing.

Data Availability

Small RNA and total RNA sequencing data have been deposited at the NCBI Gene Expression Omnibus (GEO) database and are accessible through GEO series number GSE173837. All other relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 681213 - REpiReg) (M.B.) and the Novartis Research Foundation (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Castel SE, Martienssen RA. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nature Reviews Genetics. 2013;14: 100–112. doi: 10.1038/nrg3355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Czech B, Munafò M, Ciabrelli F, Eastwood EL, Fabry MH, Kneuss E, et al. piRNA-Guided Genome Defense: From Biogenesis to Silencing. Annu Rev Genet. 2018;52: 131–157. doi: 10.1146/annurev-genet-120417-031441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moazed D. Small RNAs in transcriptional gene silencing and genome defence. Nature. 2009;457: 413–420. doi: 10.1038/nature07756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Swarts DC, Makarova K, Wang Y, Nakanishi K, Ketting RF, Koonin EV, et al. The evolutionary journey of Argonaute proteins. Nature structural & molecular biology. 2014;21: 743–753. doi: 10.1038/nsmb.2879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Meister G. Argonaute proteins: functional insights and emerging roles. Nature Reviews Genetics. 2013;14: 447–459. doi: 10.1038/nrg3462 [DOI] [PubMed] [Google Scholar]
  • 6.Volpe TA, Kidner C, Hall IM, Teng G, Grewal SIS, Martienssen RA. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science. 2002;297: 1833–1837. doi: 10.1126/science.1074973 [DOI] [PubMed] [Google Scholar]
  • 7.Reinhart BJ, Bartel DP. Small RNAs Correspond to Centromere Heterochromatic Repeats. Science. 2002;297: 1831–1831. doi: 10.1126/science.1077183 [DOI] [PubMed] [Google Scholar]
  • 8.Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, Grewal SIS, et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Sci New York N Y. 2004;303: 672–6. doi: 10.1126/science.1093686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Noma K, Sugiyama T, Cam H, Verdel A, Zofall M, Jia S, et al. RITS acts in cis to promote RNA interference–mediated transcriptional and post-transcriptional silencing. Nature Genetics. 2004;36: 1174–1180. doi: 10.1038/ng1452 [DOI] [PubMed] [Google Scholar]
  • 10.Schalch T, Job G, Noffsinger VJ, Shanker S, Kuscu C, Joshua-Tor L, et al. High-affinity binding of Chp1 chromodomain to K9 methylated histone H3 is required to establish centromeric heterochromatin. Molecular cell. 2009;34: 36–46. doi: 10.1016/j.molcel.2009.02.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Motamedi MR, Verdel A, Colmenares SU, Gerber SA, Gygi SP, Moazed D. Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs. Cell. 2004;119: 789–802. doi: 10.1016/j.cell.2004.11.034 [DOI] [PubMed] [Google Scholar]
  • 12.Bayne EH, White SA, Kagansky A, Bijos DA, Sanchez-Pulido L, Hoe K-L, et al. Stc1: a critical link between RNAi and chromatin modification required for heterochromatin integrity. Cell. 2010;140: 666–677. doi: 10.1016/j.cell.2010.01.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sugiyama T, Cam H, Verdel A, Moazed D, Grewal SIS. RNA-dependent RNA polymerase is an essential component of a self-enforcing loop coupling heterochromatin assembly to siRNA production. Proceedings of the National Academy of Sciences of the United States of America. 2005;102: 152–157. doi: 10.1073/pnas.0407641102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Colmenares SU, Buker SM, Bühler M, Dlakić M, Moazed D. Coupling of double-stranded RNA synthesis and siRNA generation in fission yeast RNAi. Molecular cell. 2007;27: 449–461. doi: 10.1016/j.molcel.2007.07.007 [DOI] [PubMed] [Google Scholar]
  • 15.Yu R, Wang X, Moazed D. Epigenetic inheritance mediated by coupling of RNAi and histone H3K9 methylation. Nature. 2018;558: 615–619. doi: 10.1038/s41586-018-0239-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sigova A. A single Argonaute protein mediates both transcriptional and posttranscriptional silencing in Schizosaccharomyces pombe. Genes & development. 2004;18: 2359–2367. doi: 10.1101/gad.1218004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Iida T, Nakayama J-I, Moazed D. siRNA-mediated heterochromatin establishment requires HP1 and is associated with antisense transcription. Molecular cell. 2008;31: 178–189. doi: 10.1016/j.molcel.2008.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kowalik KM, Shimada Y, Flury V, Stadler MB, Batki J, Bühler M. The Paf1 complex represses small-RNA-mediated epigenetic gene silencing. Nature. 2015;520: 248–252. doi: 10.1038/nature14337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Simmer F, Buscaino A, Kos-Braun IC, Kagansky A, Boukaba A, Urano T, et al. Hairpin RNA induces secondary small interfering RNA synthesis and silencing in trans in fission yeast. EMBO reports. 2010;11: 112–118. doi: 10.1038/embor.2009.273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Flury V, Georgescu PR, Iesmantavicius V, Shimada Y, Kuzdere T, Braun S, et al. The Histone Acetyltransferase Mst2 Protects Active Chromatin from Epigenetic Silencing by Acetylating the Ubiquitin Ligase Brl1. Molecular cell. 2017;67: 294–307.e9. doi: 10.1016/j.molcel.2017.05.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Reyes-Turcu FE, Zhang K, Zofall M, Chen E, Grewal SIS. Defects in RNA quality control factors reveal RNAi-independent nucleation of heterochromatin. Nat Struct Mol Biol. 2011;18: 1132–1138. doi: 10.1038/nsmb.2122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Clark JP, Rahman R, Yang N, Yang LH, Lau NC. Drosophila PAF1 Modulates PIWI/piRNA Silencing Capacity. Curr Biol. 2017;27: 2718–2726.e4. doi: 10.1016/j.cub.2017.07.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Duempelmann L, Mohn F, Shimada Y, Oberti D, Andriollo A, Lochs S, et al. Inheritance of a Phenotypically Neutral Epimutation Evokes Gene Silencing in Later Generations. Molecular cell. 2019;74: 534–541.e4. doi: 10.1016/j.molcel.2019.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chandler VL. Paramutation: from maize to mice. Cell. 2007;128: 641–645. doi: 10.1016/j.cell.2007.02.007 [DOI] [PubMed] [Google Scholar]
  • 25.Duempelmann L, Skribbe M, Bühler M. Small RNAs in the Transgenerational Inheritance of Epigenetic Information. Trends Genetics Tig. 2020;36: 203–214. doi: 10.1016/j.tig.2019.12.001 [DOI] [PubMed] [Google Scholar]
  • 26.Sadeghi L, Prasad P, Ekwall K, Cohen A, Svensson JP. The Paf1 complex factors Leo1 and Paf1 promote local histone turnover to modulate chromatin states in fission yeast. Embo Rep. 2015;16: 1673–1687. doi: 10.15252/embr.201541214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yu R, Jih G, Iglesias N, Moazed D. Determinants of Heterochromatic siRNA Biogenesis and Function. Molecular cell. 2013; 1–15. doi: 10.1016/j.molcel.2013.11.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Carl SH, Duempelmann L, Shimada Y, Bühler M. A fully automated deep learning pipeline for high-throughput colony segmentation and classification. Biol Open. 2020;9: bio052936. doi: 10.1242/bio.052936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Casañal A, Kumar A, Hill CH, Easter AD, Emsley P, Degliesposti G, et al. Architecture of eukaryotic mRNA 3’-end processing machinery. Science. 2017;358: 1056–1059. doi: 10.1126/science.aao6535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lock A, Rutherford K, Harris MA, Hayles J, Oliver SG, Bähler J, et al. PomBase 2018: user-driven reimplementation of the fission yeast database provides rapid and intuitive access to diverse, interconnected information. Nucleic Acids Res. 2018;47: gky961–. doi: 10.1093/nar/gky961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Herr AJ, Molnàr A, Jones A, Baulcombe DC. Defective RNA processing enhances RNA silencing and influences flowering of Arabidopsis. Proc National Acad Sci. 2006;103: 14994–15001. doi: 10.1073/pnas.0606536103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Vo TV, Dhakshnamoorthy J, Larkin M, Zofall M, Thillainadesan G, Balachandran V, et al. CPF Recruitment to Non-canonical Transcription Termination Sites Triggers Heterochromatin Assembly and Gene Silencing. Cell Reports. 2019;28: 267–281.e5. doi: 10.1016/j.celrep.2019.05.107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chen Y-CA, Stuwe E, Luo Y, Ninova M, Le Thomas A, Rozhavskaya E, et al. Cutoff Suppresses RNA Polymerase II Termination to Ensure Expression of piRNA Precursors. Mol Cell. 2016;63: 97–109. doi: 10.1016/j.molcel.2016.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mohn F, Sienski G, Handler D, Brennecke J. The Rhino-Deadlock-Cutoff Complex Licenses Noncanonical Transcription of Dual-Strand piRNA Clusters in Drosophila. Cell. 2014;157: 1364–1379. doi: 10.1016/j.cell.2014.04.031 [DOI] [PubMed] [Google Scholar]
  • 35.Lee SY, Hung S, Esnault C, Pathak R, Johnson KR, Bankole O, et al. Dense Transposon Integration Reveals Essential Cleavage and Polyadenylation Factors Promote Heterochromatin Formation. Cell Reports. 2020;30: 2686–2698.e8. doi: 10.1016/j.celrep.2020.01.094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Greener A, Callahan M, Jerpseth B. An efficient random mutagenesis technique using anE.coli mutator strain. Mol Biotechnol. 1997;7: 189–195. doi: 10.1007/BF02761755 [DOI] [PubMed] [Google Scholar]
  • 37.Sun Y, Zhang Y, Hamilton K, Manley JL, Shi Y, Walz T, et al. Molecular basis for the recognition of the human AAUAAA polyadenylation signal. Proceedings of the National Academy of Sciences of the United States of America. 2018;115: E1419–E1428. doi: 10.1073/pnas.1718723115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Torres-Garcia S, Yaseen I, Shukla M, Audergon PNCB, White SA, Pidoux AL, et al. Epigenetic gene silencing by heterochromatin primes fungal resistance. Nature. 2020; 1–6. doi: 10.1038/s41586-020-2706-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Calo S, Shertz-Wall C, Lee SC, Bastidas RJ, Nicolás FE, Granek JA, et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. Nature. 2014;513: 555–558. doi: 10.1038/nature13575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chang Z, Billmyre RB, Lee SC, Heitman J. Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides. Plos Genet. 2019;15: e1007957. doi: 10.1371/journal.pgen.1007957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bahler J, Wu JQ, Longtine MS, Shah NG, McKenzie A, Steever AB, et al. Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast. 1998;14: 943–951. doi: [DOI] [PubMed] [Google Scholar]
  • 42.Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetJournal. 2011;17: 10–12. 10.14806/ej.17.1.200 [DOI] [Google Scholar]
  • 43.Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology. 2009;10: R25. doi: 10.1186/gb-2009-10-3-r25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The Human Genome Browser at UCSC. Genome Res. 2002;12: 996–1006. doi: 10.1101/gr.229102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29: 15–21. doi: 10.1093/bioinformatics/bts635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30: 923–930. doi: 10.1093/bioinformatics/btt656 [DOI] [PubMed] [Google Scholar]
  • 47.Lawrence M, Gentleman R, Carey V. rtracklayer: an R package for interfacing with genome browsers. Bioinformatics. 2009;25: 1841–1842. doi: 10.1093/bioinformatics/btp328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Shimada Y, Mohn F, Bühler M. The RNA-induced transcriptional silencing complex targets chromatin exclusively via interacting with nascent transcripts. Genes & development. 2016;30: 2571–2580. doi: 10.1101/gad.292599.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Scotto–Lavino E, Du G, Frohman MA. 3′ End cDNA amplification using classic RACE. Nat Protoc. 2006;1: 2742–2745. doi: 10.1038/nprot.2006.481 [DOI] [PubMed] [Google Scholar]
  • 50.Zimmermann L, Stephens A, Nam S-Z, Rau D, Kübler J, Lozajic M, et al. A Completely Reimplemented MPI Bioinformatics Toolkit with a New HHpred Server at its Core. J Mol Biol. 2018;430: 2237–2243. doi: 10.1016/j.jmb.2017.12.007 [DOI] [PubMed] [Google Scholar]
  • 51.Madeira F, Park Y mi, Lee J, Buso N, Gur T, Madhusoodanan N, et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 2019;47: W636–W641. doi: 10.1093/nar/gkz268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215: 403–410. doi: 10.1016/S0022-2836(05)80360-2 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Wendy A Bickmore, Michael Freitag

14 Feb 2021

Dear Dr Buehler,

Thank you very much for submitting your Research Article entitled 'An enhancer screen identifies new suppressors of small-RNA-mediated epigenetic gene silencing' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by three independent peer reviewers, all experts in the field. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

The reviewers agree that your manuscript addresses an important topic, of interest to a wide audience of researchers interested in the generation and maintenance of heterochromatic regions by siRNA. They stress the novelty of finding a role for CPF in this type of gene silencing. However, the reviewers also agree on the necessity for some additional experimentation, including providing controls that are lacking in the current version of your manuscript; please pay special attention to controls for experiments shown in Figure 1 (reviewer 1 calls this “Figure 1D” but likely means Fig. 1C). Reviewer 3 also suggests use of a second, independent reporter gene, something worth considering, as useful fission yeast strains may exist. Reviewer 2 points out two major issues, namely the lack of evidence for “unprocessed transcripts retained on chromatin” (related to Figure 4) and the absence for a phenotypic assay for phosphatase mutants, which should be included to support your conclusions. Reviewer 1 suggests ChIP assays to exclude indirect effects. Lastly, Reviewer 2 also suggests assaying ade6 transcript levels “in yth1-R59C, A4 PAS, and phosphatase mutants compared to wild-type cells”. While the reviewer admits that levels may not be drastically changed, this seems like an important issue to address in a revised version. There are several other major comments that warrant attention, including referring to previous work, as suggested by reviewers 1 and 3. Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Michael Freitag

Associate Editor

PLOS Genetics

Wendy Bickmore

Section Editor: Epigenetics

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: It is well known that RNAi machinery is critical for heterochromatin formation at fission yeast centromeres as siRNAs recruit CLRC (Clr4 methyltransferase complex) in cis. However, it has been reported that siRNAs cannot act in trans to trigger heterochromatin at targeted euchromatic locations with the exception of genetic backgrounds that allow such process (e.g. paf1, mst2, mlo3). In this ms. Shimada and colleagues perform a forward genetic screen that identify suppressors of the “trans-acting” small-RNA-mediated epigenetic silencing. The system, already used by the authors in previous papers, consists of a reporter strain that expresses an RNA hairpin on chromosome I that is complementary to an ade6+ reporter gene on chromosome II. In a wild type “naïve” condition, colonies are white (i.e. ade6+ ON). However, if the tester strain acquires enabling mutations yeast colonies become red (i.e. ade6+ OFF), which allows the authors to find 20 novel mutants for genes involved in RNA processing, regulation of transcription, etc. Of outstanding interest, a mutant in Yth1, a component of the conserved CPF (Cleavage and Polyadenylation Factor), display the highest levels of silencing. Such result is counterintuitive since CPF has been recently found to be involved in heterochromatin formation by an RNAi-independent mechanism. The authors also report that mutations in non-essential genes of CPF complex allow trans-silencing, proposing a model in which defective RNA processing delays nascent transcript release from chromatin, allowing sufficient time for the siRNA-guided RITS to recruit CLRC. In summary, this study is in principle interesting for the fission yeast and heterochromatin communities. However, I think that more experimental evidence is required to support the proposed model. In addition, essential controls are missing in some figures. Please find my comments and suggestions below.

Major issues:

_Figure 1D: Some critical controls are missing such as wild-type (with or without nmt1:ade6-hp+) and the identified mutants, in particular yth1-R59C, lacking the hairpin. This data must be included to rule out any indirect effect (e.g. mutants displaying red color per se). This information can be presented as dilution assays given the number of strains involved.

_Figure 2E: Can the authors rule out a mere redistribution of heterochromatin from other locations to the trp1::ade6+ region? For example, in Shelterin mutants, heterochromatin released from telomeres can relocate to centromeres thus suppressing RNAi mutants (Tadeo et al., 2013 -Jia Group)

_Figure 3E: The authors shall also show colony color pictures directly comparing yth1-R59C to PAS A4 mutants. This is a critical for ruling indirect effects caused by CPF mutants. I would expect similar levels of silencing between these mutants if the authors’ model is correct. Also, the levels of H3K9me2 in PAS A4 mutants as compared to yth1-R59C needs to be shown.

_In addition, ChIP analyses for Yth1 and Yth1-R59C is needed to rule out any indirect effect. I would expect lower enrichment for the mutant at the trp1:ade6+.

_Citations are missing as follows:

Lines 241-243: Please cite Lee et al. 2020 (PMID: 32101745), since this paper also identified CPF factors involved in heterochromatin formation.

Introduction: The section describing siRNA becoming potent mediators of RNAi-mediated epigenetic silencing in mutants such as mlo3∆ is missing an important reference. The authors must acknowledge a paper by Reyes-Turcu et al. NSMB 2011 (PMID: 21892171; Grewal group) that was first to show that cells lacking mlo3 show hairpin-induced heterochromatin assembly (see fig S7). Reyes-Turcu et al also showed that treatment of cells 6-AU enhances hairpin-induced heterochromatin assembly. The system is very similar to that used later in Kowalik et al., 2015.

The authors also discuss an RNAi positive feedback loop. This positive feedback loop was first discovered by Noma et al (PMID: 15475954) and then further described by Sugiyama et al (PMID: 15615848). These papers should be referenced along with work by the authors.

Minor comments:

_Lines 188-190: How mst2+ strains were obtained? While some information is available in Materials and Methods, it is important to point out that strains are not coming from crosses, so it is not mere maintenance of silencing state carried from the mst2∆ background.

_Fig. 2C. Are the other mutants affecting initiation of silencing as well? Any additional data would be useful in a supp. figure. Similarly, initiation of silencing rates in CPF mutants would be helpful as well.

_Fig. 2E. p values should be written as “0.01” instead of “0,01” and so on.

_Fig. 3A: I wonder how CPF mutants were obtained. Where these strains obtained from crosses involving an already ade6+ silenced? Please clarify.

_Fig. 4B-D. If data is available for pfs2 mutant, that should be included.

_Fig. 4C. Is the reverse oligo annealing after the cleavage site? Please clarify.

_Table S3 and S4: please indicate in which figure/s the strains or oligos have been employed. That will help the reader.

Reviewer #2: The role of small interfering non-coding RNAs in promoting de novo heterochromatin formation in cis was described almost two decades ago using the fission yeast Schizosaccharomyces pombe. Since then, many groups have dissected in detail many of the different components that are required for establishing RNAi-dependent heterochromatin domains at non-coding repeats.

Interestingly, contrary to the effect observed in cis, it has consistently been reported that in wild-type cells, siRNAs derived from a hairpin construct (or alternatively from a source gene inserted within heterochromatin repeats) do not lead to effective transcriptional silencing of a complementary target sequence in trans. However, this refractory effect was shown to be suppressed in the presence of specific enabling mutations, such as those in the Paf1 complex or the mRNA export factor Mlo3.

In this manuscript, Shimada et al. report the identification of 20 novel mutant alleles that enable hairpin-derived siRNAs to mediate transcriptional silencing of a target ade6 gene in trans. The authors followed the same strategy that led to the identification of Paf1C mutants in a previous study (Kowalik et al., 2015) but here, to maximise the chances of obtaining trans silencing-enabling mutations, the authors performed their EMS screen in a mst2D background.

Of 20 identified alleles, the authors decided to focus on yth1-R59C, encoding a mutant of the CPF complex subunit Yth1, which showed the strongest silencing phenotype. Indeed, yth1-R59C cells exhibited a remarkably high rate of silencing establishment. Furthermore, using a mutagenized plasmid library-based strategy, the authors identified additional mutations in yth1 that enable siRNA-mediated silencing. Modelling the identified yth1 mutations on the structure of human CPF revealed that R59C has the potential to disturb the interaction with adenosine at position 4 of the pre-mRNA PAS. Consistent with this hypothesis, the authors showed that strains harbouring mutations in A4 of the ade6 PAS are able to establish siRNA-mediated silencing in the absence of yth1-R59C or other enabling mutations.

A mutation in Pfs2 (another CPF component) was also found to allow siRNA-mediated silencing to occur in trans, and a similar effect was proposed to be achieved upon deletion of several CPF phosphatase module components.

Lastly, in an attempt to consolidate their previously-proposed kinetic nascent transcript processing model for the inhibition of siRNA-mediated de novo heterochromatin establishment, the authors show that in strains harbouring yth1-R59C or A4 mutations, ade6 pre-mRNA cleavage is reduced.

The manuscript is in general well-written and easy to follow. Even though mutations that enable siRNA-mediated silencing in trans have been described before, this work is of interest as it certainly provides a list of novel enabling mutations, some of which occurred in uncharacterized factors or components with biological roles not previously associated with siRNA-mediated silencing. However, further mechanistic insights should be provided regarding the role of yth1 mutations in enabling siRNA-mediated silencing through the previously proposed kinetic nascent transcript processing model, as the presented experiments only further solidify the correlation between siRNA-mediated silencing establishment and levels of non-cleaved pre-mRNA.

Major points:

1. In the abstract, the authors state: ‘Our results provide direct evidence for a kinetic nascent transcript processing model‘, yet experiments presented in Figure 4 only show that yth1-R59C cells exhibit reduced cleavage of ade6 pre-mRNA. No evidence of unprocessed transcripts being retained on chromatin is provided. The authors should directly test if an increase in chromatin-bound unprocessed ade6 transcripts in yth1-R59C cells is associated with the observed high silencing establishment rate. Can the high silencing establishment frequency of yth1-R59C be suppressed by engineering pre-mRNA cleavage (e.g. ribozyme insertion as used in S. cerevisiae Mol Cell 2003 12:711 ) and release from chromatin?

2. Although the establishment of siRNA-mediated silencing at a complementary sequence in trans has previously been shown to correlate with secondary siRNA generation at the target site, no experiments aimed at detecting those were performed here. Confirming the presence of secondary siRNAs is of special importance in yth1-R59C cells, since the authors performed substantial follow-up experiments to elucidate the mechanism by which this mutation enables silencing.

3. Line 303-305: ‘CPF mutants that we have investigated in this study phenocopy wild type cells, i.e. neither growth nor gene expression is noticeably affected.’

- There seems to be a small but noticeable difference in colony size when comparing yth1 mutants to wild-type cells. These differences can be observed in YES plates of Figure 3B and Figure 4A (also for dis2D and ssu72D mutants).

- Quantitative analyses of ade6 mRNA levels (without ade6-hp) in yth1-R59C, A4 PAS, and phosphatase mutants compared to wild-type cells are not shown in this manuscript. Although a strong change in ade6 mRNA levels is not expected in yth1-R59C and A4 mutants by looking at the phenotypes shown in Figure 2B (no ade6-hp, dcr1+) and 3E, ade6 mRNA levels should be quantitatively assessed in these conditions and compared to levels observed in wild-type cells. Figure 4B shows differences in cleavage among mutants but does not compare total levels. Figure 4C (bottom) suggests that ade6 mRNA levels in mutants are equal to wild-type but a loading control was not included in this experiment.

- For phosphatase mutants, in addition to quantitatively assessing ade6 mRNA levels, a phenotype (colour) assay should be shown in the absence of ade6-hp or alternatively in the presence of ade6-hp but in a dcr1D background. Data shown in Figure 4 are not enough to support the conclusion that these mutations enable siRNA-mediated silencing (this is of importance given that these mutations did not come up in the screen which excluded mutants in the adenine pathway).

Other points:

- Figure 4 and text lines 331/337 refer to yth1-G59C instead of yth1-R59G which made the respective figure and text highly confusing.

- Some pink colonies are formed in p-yth1+-containing cells in YE medium. Is this due to differences in plasmid stability among clones?

- Given that phosphatase mutants do not affect pre-mRNA cleavage, could the authors speculate on how these mutations lead to siRNA-mediated silencing?

- The use of the term ‘tester strain’ is at times confusing as it is unclear whether this refers to the original mst2+ tester strain used in Kowalik et al. (2015) or the mst2D strain used in this study. I suggest adding mst2+ or mst2D in between brackets every time ‘tester strain’ is mentioned.

- Figure 2C/D/E. Please indicate genotype either in panels or in legend (no mention of ade6-hairpin is made for those panels).

- Including the silencing establishment frequency for each of the identified mutant alleles (both in mst2D and mst2+ backgrounds) in Table 2 would be helpful to the community.

- Line 291 - Forgoing > Foregoing?

- Figure 4C/D: Diagrams illustrating primer locations (C (top) and D) are confusing at they seem to indicate that the amplicon in D is longer than C (top).

- Although a reference is provided, given the importance of the procedure for this study, it would be appropriate to fully describe the computational pipeline followed to identify SNPs, especially as it is indicated that an ‘adapted’ pipeline was used.

Reviewer #3: Heterochromatin is essential for genome stability and gene expression. Small interference RNAs (siRNAs) have been shown to plays an important role in peri-centromeric heterochromatin, which contains repetitive DNA, in fission yeast. However, the protein-coding genes in euchromatin are resistant to siRNA-mediated heterochromatin formation. The mechanism used for counteracting heterochromatin assembly remains largely unclear. Through an elegant genetic screen, Shimada et al. identified more than twenty mutant alleles that enable de novo formation of heterochromatin at a protein-coding gene in euchromatin. By further characterizing a novel factor they identified, the pre-mRNA cleavage factor Yth1, they provides new insight into how small-RNA-directed de novo formation of heterochromatin in euchromatin is inhibited. This work is scientifically interesting and significant. The experiments were in general well designed and carefully executed, and most of the results are convincing. There are several concerns as listed below.

Major:

1. There is a concern about the indirect effect on the expression of the ade6 reporter used in the genetic screen in the mutant backgrounds. The study will be strengthened by confirming the de novo heterochromatin formation using growth assays having a different reporter.

2. Figure 1C should have a wild type control.

3. The study would be benefited by analyzing mutants with de novo heterochromatin formation in the clr4 mutant background using same growth assays. This would further confirm that the de novo heterochromatin formation depends on H3K9 methylation.

4. It would be interesting to compare the de novo heterochromatin silencing in these mutants with the native pericentromere silencing, such as H3K9 methyation and RNA transcription level of the reporter in the two regions.

5. In Introduction, Line 94, the statement “Whereas siRNAs originating from heterochromatic repeats function well in cis to sustain H3K9 methylation, they do not act in trans to mediate de novo formation of heterochromatin at complementary sequences in wild type cells “ is inaccurate. It has been shown that siRNAs can act in trans to induce heterochromatin formation at complementary sequences in pericentromeres in Chromosome III in wild type fission yeast cells (Haijin He, et al. Cell Reports, 2016).

Minor

1. The media used in this paper should be listed in the Materials and Methods section.

2.Line 570, it should be “wild-type”, not “wildtype”.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: The source data underlying Figure 2C/D/E, Figure 3E/G and Figure 4B do not seem to be provided.

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Wendy A Bickmore, Michael Freitag

4 Jun 2021

Dear Dr Bühler,

We are pleased to inform you that your manuscript entitled "An enhancer screen identifies new suppressors of small-RNA-mediated epigenetic gene silencing" has been editorially accepted for publication in PLOS Genetics. Congratulations!

In your point-for-point response you addressed all comments of the three reviewers, you added the requested experimental data, and you made changes that were suggested to soften some of your conclusions, reflecting the data produced in your study. Thanks for sending this interesting work to PLOS Genetics! 

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Michael Freitag

Associate Editor

PLOS Genetics

Wendy Bickmore

Section Editor: Epigenetics

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-01839R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Wendy A Bickmore, Michael Freitag

16 Jun 2021

PGENETICS-D-20-01839R1

An enhancer screen identifies new suppressors of small-RNA-mediated epigenetic gene silencing

Dear Dr Bühler,

We are pleased to inform you that your manuscript entitled "An enhancer screen identifies new suppressors of small-RNA-mediated epigenetic gene silencing" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. ade6+ silencing in the newly identified point-mutants depends on a functional RNAi pathway.

    Serial dilution assays showing the ade6+ silencing phenotypes (red color when grown on YE plates) in the respective mutant cells. Silencing is not observed in the absence of Dicer (dcr1Δ). Cells are mst2+ but harbor mutations in individual genes as indicated.

    (TIF)

    S2 Fig. Most of the newly identified point-mutants with a low silencing initiation rate have a higher maintenance of silencing rate.

    Comparison of initiation (A) and maintenance (B) of ade6+ silencing in the mutant cells as indicated (trp1+::ade6+, nmt1+::ade6-hp+). Multiple individual originator colonies (white or red in A or B, respectively) were spread to single cell density on YE plates to assess initiation/maintenance of the silencing phenotype. Number of originator colonies and total counted number of colonies (in brackets) are indicated on top of the graphs.

    (TIF)

    S3 Fig. Expression of siRNAs in cells with weakened CPF/AAUAAA RNA interactions triggers RNAi-mediated heterochromatin silencing of protein coding genes in trans.

    (A) RNAi-directed silencing in yth1-R59C cells is not unique to the trp1+::ade6+ silencing reporter. The yth1-R59C mutation was introduced into cells that express synthetic ura4-hp siRNAs instead of ade6-hp siRNAs, and a trp1+::ura4+ instead of a trp1+::ade6+ reporter. ura4DS/E denotes a partial deletion of the endogenous ura4+ gene. Silencing of the ura4+ reporter was assessed by growth in the presence or absence of 5-FOA (which is toxic to ura4+ expressing cells). Note that 5-FOA resistant colonies did only form in the presence of ura4-hp siRNAs and simultaneous mutation of yth1+. (B) Silencing assays showing the degree of ade6+ silencing in cells harboring mutations in yth1+ (yth1-R59C) or at the 4th position in the PAS of the ade6+ reporter gene. See Fig 3E for a quantification of the initiation of silencing rates in the PAS mutants. (C) Silencing assay demonstrating that trp1+::ade6+ silencing in yth1-R59C cells depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ). (D) Silencing assay demonstrating that trp1+::ade6+ silencing in pfs2-F115H cells depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ).

    (TIF)

    S4 Fig. Impairment of the CPF phosphatase module enables RNAi-mediated heterochromatin silencing.

    (A) Silencing assays demonstrating that trp1+::ade6+ silencing in CPF phosphatase module mutant cells (ssu72Δ, swd22Δ, dis2Δ, ppn1Δ) depends on RNAi (dcr1Δ, w/o ade6-hairpin) and H3K9 methylation (clr4Δ). (B and C) Comparison of initiation (B) and maintenance (C) of ade6+ silencing in CPF phosphatase module mutant cells (trp1+::ade6+, nmt1+::ade6-hp+). Multiple individual originator colonies (white or red in B or C, respectively) were spread to single cell density on YE plates to assess initiation/maintenance of the silencing phenotype. Number of originator colonies and total counted number of colonies (in brackets) are indicated on top of the graphs.

    (TIF)

    S5 Fig. Steady-state mRNA levels remain largely unaffected in cells harboring RNAi-enabling CPF mutations.

    (A) Quantitative RT-PCR with primer pairs amplifying ade6+ or act1+ mRNAs in the respective mutant strains, which do not express any ade6+ siRNA. mRNA levels were normalized to U6snRNA and are shown relative to the levels measured in wild-type cells. Error bars indicate standard deviation, n = 3 independent biological replicates. (B) Pairwise comparisons of gene expression (RNA-seq) between wild-type and CPF or trp1+::ade6+ PAS mutant strains. Cells did not express primary ade6-hairpin siRNAs. Fragments per kilobase million (FPKMs) were calculated and averaged over three replicates. Each scatterplot depicts log2-transformed FPKM values of the wild-type against one of the mutants.

    (TIF)

    S1 Table. EMS type mutations identified by Illumina whole genome next-generation sequencing

    (XLSX)

    S2 Table. List of S. pombe strains used in this study.

    (XLSX)

    S3 Table. List of plasmids used in this study.

    (XLSX)

    S4 Table. List of primers used in this study.

    (XLSX)

    S1 Data. Values used to generate box plot shown in Fig 2C.

    (XLSX)

    S2 Data. Values used to generate box plot shown in Fig 2D.

    (XLSX)

    S3 Data. Values used to generate graph shown in Fig 2E.

    (XLSX)

    S4 Data. Values used to generate box plot shown in Fig 3E.

    (XLSX)

    S5 Data. Values used to generate box plot shown in Fig 3G.

    (XLSX)

    S6 Data. Values used to generate graphs shown in Fig 5C.

    (XLSX)

    S7 Data. Values used to generate box plots shown in S2 Fig.

    (XLSX)

    S8 Data. Values used to generate box plots shown in S4B and S4C Fig.

    (XLSX)

    S9 Data. Values used to generate graph shown in S5A Fig.

    (XLSX)

    Attachment

    Submitted filename: Point-by-point Response_Shimada_Final.docx

    Data Availability Statement

    Small RNA and total RNA sequencing data have been deposited at the NCBI Gene Expression Omnibus (GEO) database and are accessible through GEO series number GSE173837. All other relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES